Brevan Howard Capital Management LP Ironwood Pharmaceuticals Inc Transaction History

Brevan Howard Capital Management LP

  • $14.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.58 - $8.61 $218,881 - $337,735
39,226 Added 135.38%
68,200 $444,000
Q1 2024

May 15, 2024
SELL
$8.32 - $15.45 $163,521 - $303,654
-19,654 Reduced 40.42%
28,974 $252,000
Q4 2023

Feb 14, 2024
BUY
$8.79 - $11.51 $427,440 - $559,708
48,628 New
48,628 $556,000

Others Institutions Holding IRWD

# of Institutions
237
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $616M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email